| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/30/1992 | US5126127 Stabilized PVP-I solutions |
| 06/30/1992 | US5126125 Decreasing the melanin content in mammalian skin and hair using 5,6-dihydroxindole derivatives |
| 06/30/1992 | CA1304391C Lipoxygenase inhibiting compounds |
| 06/30/1992 | CA1304390C Phenyl hydroxamic acids including a hetero-containing substituent |
| 06/30/1992 | CA1304385C2 Process for producing tetramic acid |
| 06/30/1992 | CA1304383C 1-alkyl-1-sulfonyl-2-alkoxycarbonylsulfenyl hydrazines having antineoplastic activity |
| 06/30/1992 | CA1304381C 3-(piperidin-1-yl)-carbonylmethyl-isoindolin-1-one |
| 06/30/1992 | CA1304376C Imidazolidinone compound and processes for preparation thereof |
| 06/30/1992 | CA1304375C Benzylaminoaryl-dihydropyridinelactones, process for their preparation, and their use in medicaments |
| 06/30/1992 | CA1304360C Use of 2',3'-dideoxycytidin-2'-ene (2',3'-dideoxy-2', 3'-didehydrocytidine) in treating patients infected with retroviruses |
| 06/30/1992 | CA1304359C Antitumor and antiviral compositions of marine origin |
| 06/30/1992 | CA1304358C Macrolide compounds |
| 06/30/1992 | CA1304296C Percutaneous-administration-type pharmaceutical preparation of nitroglycerin |
| 06/30/1992 | CA1304295C Anesthetic composition and method of using the same |
| 06/30/1992 | CA1304294C Pharmaceutical preparations with extended release |
| 06/30/1992 | CA1304196C Method of treating contact lenses |
| 06/29/1992 | WO1992012148A1 1,4-benzothiazepine derivative |
| 06/29/1992 | WO1992012140A1 Peptides ketoamides, ketoacids, and ketoesters |
| 06/29/1992 | WO1992011850A2 Use of calpain inhibitors in the inhibition and treatment of neurodegeneration |
| 06/29/1992 | CA2098702A1 Peptide ketoamides, ketoacids, and ketoesters |
| 06/29/1992 | CA2098609A1 Use of calpain inhibitors in the inhibition and treatment of neurodegeneration |
| 06/29/1992 | CA2058471A1 Multicomponents agent or preparation kit for producing the sulfo-conjugated form of pyridino-, pyrimidino- or triazino-n-oxide compounds and process therefor |
| 06/28/1992 | WO1992012147A1 Process for the preparation of substituted benzofuran derivatives |
| 06/28/1992 | WO1992012137A1 Novel 3(2h)-pyridazinones, pharmaceutical compositions containing them and process for preparing same |
| 06/28/1992 | CA2099107A1 Process for the preparation of substituted benzofuran derivatives |
| 06/28/1992 | CA2074261A1 3(2h)-pyridazinones, pharmaceutical compositions containing them and process for preparing same |
| 06/28/1992 | CA2058457A1 Method for inhibiting ige production |
| 06/28/1992 | CA2057973A1 Method for alleviating anxiety using benzobicyclic carboxamides |
| 06/27/1992 | CA2058384A1 Certain (arylsulfonamido- and pyridyl- or imidazolyl-) substituted carboxylic acids and derivatives thereof |
| 06/27/1992 | CA2058086A1 Hair growth stimulator |
| 06/27/1992 | CA2057834A1 Pentamidine solution with neutral ph and method for administration thereof |
| 06/26/1992 | WO1992011246A1 Novel benzodiazepine derivative |
| 06/26/1992 | CA2099672A1 Benzodiazepine derivatives |
| 06/26/1992 | CA2058060A1 Deacetylcolchicine derivatives |
| 06/25/1992 | WO1992011258A1 Thiangazole, its preparation, compositions and use thereof |
| 06/25/1992 | WO1992011011A1 Use of certain glutarimide derivatives in the treatment of depression and mania |
| 06/25/1992 | WO1992010997A1 Flavor stable zinc acetate compositions for oral absorption |
| 06/25/1992 | WO1992010828A1 Folded sheet means |
| 06/25/1992 | WO1992010573A1 Methods and compositions for the suppression of neu mediated transformation |
| 06/25/1992 | WO1992010498A1 Novel csaids |
| 06/25/1992 | WO1992010497A1 ENANTIOMERICALLY PURE β-D-(-)-DIOXOLANE-NUCLEOSIDES |
| 06/25/1992 | WO1992010496A1 ENANTIOMERICALLY PURE β-L-(-)-1,3-OXATHIOLANE NUCLEOSIDES |
| 06/25/1992 | WO1992010493A1 Polymorphs of crystalline mupirocin |
| 06/25/1992 | WO1992010492A1 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds useful as antibacterial agents |
| 06/25/1992 | WO1992010491A1 Antiallergic compounds |
| 06/25/1992 | WO1992010485A1 A process for the preparation of diltiazem |
| 06/25/1992 | WO1992010482A1 Pharmaceutical compositions containing functionalized vinylazoles, use of these vinylazoles for producing medicaments, these vinylazoles themselves and process for producing the same |
| 06/25/1992 | WO1992010477A1 Medicaments |
| 06/25/1992 | WO1992010473A2 2-decarboxyl-2-alkoxyalkyl prostaglandins as ocular hypotensives |
| 06/25/1992 | WO1992010468A1 Anti-atherosclerotic aryl compounds |
| 06/25/1992 | WO1992010212A1 Anthracycline-conjugates |
| 06/25/1992 | WO1992010203A1 A vaccine against cholesterol to prevent hypercholesterolemia and atherosclerosis |
| 06/25/1992 | WO1992010200A1 Functional interactions between glial s-100b and central nervous system serotonergic neurons |
| 06/25/1992 | WO1992010195A1 Cell proliferation matrix and use thereof |
| 06/25/1992 | WO1992010194A1 Use of antigestagenes for producing medicaments |
| 06/25/1992 | WO1992010192A1 Indan derivatives |
| 06/25/1992 | WO1992010191A1 Quinoline, naphthyridine and pyridobenzoxazine derivatives |
| 06/25/1992 | WO1992010189A1 Imidazolyl-alkenoic acids |
| 06/25/1992 | WO1992010188A1 Use of angiotensin ii receptor antagonists in the treatment of hemorragic stroke |
| 06/25/1992 | WO1992010187A1 Use of angiotensin ii antagonists in the treatment of angina pectoris |
| 06/25/1992 | WO1992010186A1 Use of angiotensn ii receptor antagonists for the preparation of a medicament for improving cognitive function |
| 06/25/1992 | WO1992010185A1 Use of angiotensin ii receptor antagonists in the prevention of restinosis |
| 06/25/1992 | WO1992010184A1 Use of angiotensin ii receptor antagonists in the treatment of atheroma |
| 06/25/1992 | WO1992010183A1 Use of angiotensin ii receptor antagonists in the treatment of diabetic retinopathy |
| 06/25/1992 | WO1992010182A1 Use of angiotensin ii receptor antagonists in the treatment of diabetic nephropathy |
| 06/25/1992 | WO1992010181A1 Use of angiotensin ii antagonists in the treatment of left ventricular hypertrophy |
| 06/25/1992 | WO1992010180A1 Use of angiotensin ii antagonist in the treatment of infarction |
| 06/25/1992 | WO1992010179A1 Use of angiotensin ii receptor antagonists in the treatment of macular degeneration |
| 06/25/1992 | WO1992010178A1 Antipruritic drug and antipruritic composition |
| 06/25/1992 | WO1992010177A1 Pharmaceutical compositions |
| 06/25/1992 | WO1992010176A1 Therapeutic agent for hepatic disease |
| 06/25/1992 | WO1992010175A1 Lyophilized amino acid compositions containing glutamine |
| 06/25/1992 | WO1992010171A1 New pharmaceutical formulations containing a pharmacologically active ionizable substance as well as process for the preparation thereof |
| 06/25/1992 | WO1992010164A1 Agent for reducing the growth of, or removing, human body hair |
| 06/25/1992 | WO1992010097A1 Angiotensin ii receptor blocking compositions |
| 06/25/1992 | WO1992009586A1 Active oxygen inhibitor |
| 06/25/1992 | WO1992008474A3 Treatment of lung diseases |
| 06/25/1992 | WO1992007564A3 Method of treating demyelinating disease |
| 06/25/1992 | WO1992006992A3 New process for biophosphorylating organic compounds |
| 06/25/1992 | DE4042007A1 6,7-modifizierte-11(beta)-aryl-4-estrene 6,7-modified-11 (beta) -Aryl-4-Estrenes |
| 06/25/1992 | DE4042005A1 D-homo-(16-en)-11(beta)-aryl-4-estrene D-homo (16-s) -11 (beta) aryl-4-Estrenes |
| 06/25/1992 | DE4042004A1 14(beta)-h-, 14- u. 15-en-11(beta)-aryl-4-estrene 14 (beta) -h, 14 u. 15-en-11 (beta) aryl-4-Estrenes |
| 06/25/1992 | DE4041981A1 Use of selective and non-selective quisqualate receptor antagonists - combined with L-DOPA and/or dopamine agonists, for treatment of Parkinson's disease |
| 06/25/1992 | DE4041559A1 Novel anti-cholinergic agents contg. quat. ammonium gps. - used to limit side effects of administration of opiate(s) and opioid(s) |
| 06/25/1992 | DE4041482A1 Neue pharmazeutische verwendung carbocyclisch und heterocyclisch annelierter dihydropyridine New pharmaceutical use carbocyclic and heterocyclic fused-dihydropyridines |
| 06/25/1992 | DE4041465A1 10-cyanmethylen-4-(piperazin-1-yl)-pyrrolo (4,3-e)benzoazepinen zur bekaempfung der migraene 10-cyanomethylene-4- (piperazin-1-yl) pyrrolo (4,3-e) benzoazepinen aimed at fighting the migraene |
| 06/25/1992 | CA2590125A1 Enantiomerically pure .beta.-d-(-)-dioxolane-nucleosides |
| 06/25/1992 | CA2098107A1 Polymorphs of crystalline mupirocin |
| 06/25/1992 | CA2097607A1 Use of certain glutarimide derivatives in the treatment of depression and mania |
| 06/25/1992 | CA2097594A1 Thiangazole, its preparation, compositions and use thereof |
| 06/25/1992 | CA2097181A1 Cell proliferation matrix and use thereof |
| 06/25/1992 | CA2096945A1 2-decarboxyl-2-alkoxyalkyl prostaglandins as ocular hypotensives |
| 06/24/1992 | EP0491664A1 Serotonin antagonists |
| 06/24/1992 | EP0491644A2 Process for obtaining polymers with antiviral activity |
| 06/24/1992 | EP0491643A2 Process for obtaining polymers with antiviral activity |
| 06/24/1992 | EP0491586A1 Use in anaesthesia and pharmaceutical compositions of (S)-isoflurane and (S)-desflurane |
| 06/24/1992 | EP0491549A1 Novel 15-nitro-2beta, 3beta-dihydro- and 15-nitro-2beta,3beta,6,7-tetrahydrotabersonine derivatives, pharmaceutical compositions containing them and process for preparing same |
| 06/24/1992 | EP0491548A2 Processes and intermediates for thromboxane receptor antagonists |
| 06/24/1992 | EP0491525A1 Benzamide and sulfonamide hypoglycemic agents |
| 06/24/1992 | EP0491443A1 Progestagen-only contraceptive |